Advancing new research
The Interlaken Leadership Awards
Interlaken Leadership Awards Recipients
Anneke van der Kooi (Netherlands)
Early intravenous immunoglobulin (IVIg) treatment in newly diagnosed idiopathic inflammatory myopathies (myositis): a proof of principle study.
Lisa Christopher-Stine (USA)
Low Dose Intravenous and Subcutaneous IG for the Maintenance Treatment of Statin-induced Anti-HMGCR-associated Myopathy: A Prospective Pilot Study.
Bart Jacobs (Netherlands)
Immunoglobulin treatment for patients with mild Guillain-Barré syndrome: an international prospective observational study.
Andrew J Pollard (UK)
Intravenous immunoglobulin in the management of encephalitis in children.
Min-Suk Yoon (Germany)
Effects of intrathecal application of human immunoglobulins (Igs) on rat EAN Model.
Josep Gamez (Spain)
Intravenous Immunoglobulin for Preparing Myasthenia Gravis Patients for Thymectomy and Other Surgical Procedures Preventing Myasthenic Crisis.
Jean-Yves Delattre (France)
IaSON: Privigen in paraneoplastic syndrome.
Christian Geis (Germany)
Treatment effects of polyvalent human immunoglobulins in an animal model of Neuromyelitis optica.
Andreas Goebel (UK)
Cellular and behavioural models to predict patients' responses to IgG treatment in CRPS.
Ruth Itzhaki (UK)
Does Privigen affect the accumulation of Aβ and P-tau that occurs in HSV1-infected cultures of Vero cells.
Jens Schmidt (Germany)
Immunoglobulin G for experimental treatment of Duchenne muscular dystrophy.
© 2017 CSL Behring